Amir‐Babak Sioofy‐Khojine

Author

Also Known As

A. B. Sioofy-Khojine, A. B. Sioofy‐Khojine, AB Sioofy-Khojine, AMIR BABAK SIOOFY-KHOJINE, Amir Babak Sioofy, Amir Babak Sioofy Khojine, Amir Babak Sioofy Khoojine, Amir Babak Sioofy-Khojine, Amir-Babak Sioofy-Khojine, Amirbabak Sioofy-Khojine

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Tampere University Fimlab (Finland)Pirkanmaa Hospital District Karolinska Institutet

About

Amir‐Babak Sioofy‐Khojine is an author at Tampere University specializing in medicine, virology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	416
2	Immunology	7	7	247
3	Diabetes	1	1	144
4	Epidemiology	1	1	144
5	Gastroenterology	1	1	11

Amir‐Babak Sioofy‐Khojine

Publications

927

Citations

H-Index

Page 1

	Year	Citations
Virus Antibody Survey in Different European Populations Indicates Risk Association Between Coxsackievirus B1 and Type 1 Diabetes Sami Oikarinen, Sisko Tauriainen, Didier Hober, Diabetes Type 1Diabetes EpidemiologyVirus EpidemiologyViral DiagnosticsImmunodeficiencies	2013	144
Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes Amir‐Babak Sioofy‐Khojine, Jussi Lehtonen, Noora Nurminen, Diabetologia Insulin-driven AutoimmunityViral PersistenceAutoimmune DiseasePathogenesisImmunology	2018	96
Echoviruses Bind Heparan Sulfate at the Cell Surface Ian Goodfellow, Amir‐Babak Sioofy‐Khojine, Robert M. Powell, Journal of Virology	2001	82
A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates Virginia M. Stone, Minna M. Hankaniemi, Olli H. Laitinen, Science Advances	2020	82
A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes Virginia M. Stone, Minna M. Hankaniemi, Emma Svedin, Diabetologia	2017	57
Infection of human islets of langerhans with two strains of coxsackie B virus serotype 1: Assessment of virus replication, degree of cell death and induction of genes involved in the innate immunity pathway Mahesh Anagandula, Sarah J. Richardson, M. Steven Oberste, Journal of Medical Virology	2013	48
Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice Tiia Koho, Minni R. L. Koivunen, Sami Oikarinen, Antiviral Research Coxsackievirus B3 VlpsMolecular VirologyPathogenesisViral PathogenesisImmunology	2014	44
Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model Minna M. Hankaniemi, Olli H. Laitinen, Virginia M. Stone, Vaccine VaccinationMolecular VirologyVaccine DevelopmentSynthetic VirologyImmunology	2017	36
Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect Virginia M. Stone, Marta Butrym, Minna M. Hankaniemi, Diabetes	2021	32
Coxsackievirus B1 reveals strain specific differences in plasmacytoid dendritic cell mediated immunogenicity Sanna Hämäläinen, Noora Nurminen, Helena Ahlfors, Journal of Medical Virology	2014	29

Page 1